Successful European ESCRS 2017 meeting for ELZA
With 10’000 participants, ESCRS has become one of the largest ophthalmological congresses in the world.
Prof. Farhad Hafezi
October 31, 2017
With 10’000 participants, ESCRS has become one of the largest ophthalmological congresses in the world.
After 4 years of preparation, the new Research Laboratory for Ocular Cell Biology and Biomechanics opens at the USC Roski Eye Institute.
Cataract & Refractive Surgery Today Europe April 2017: ELZA member and EMAGine CEO Nikki Hafezi describes the technique of CXL at the slit lamp
The Geneva University Spin-off company EMAGine will present the C-Eye device. This mobile cross-linking technology will allow for slit lamp cross-linking (CXL and PACK-CXL) treatments.
The National Keratoconus Foundation in the US highlights the work of the ELZA member Nikki Hafezi and the Swiss Light for Sight foundation, providing keratoconus treatment for children and adolescents, with special emphasis on Down Syndrome
Report on ELZA and its clinical and research activities on refractive laser surgery, cornea, keratoconus and crosslinking (article in German).
We are very proud to announce that the founder of the ELZA Institute, Prof. Farhad Hafezi, has been voted onto the PowerList 2016 by his peers, for the second time after 2014
The ELZA member Farhad Hafezi is a member of the scientific committee and the co-organizer of the upcoming CXL Experts Meeting in Zurich on December 2-3, 2016.
Cover story about the Light for Sight foundation and its efforts to bring CXL therapy to a young patient
Editorial on the OSN Roundtable discussion, written by Farhad and Nikki Hafezi from ELZA in Switzerland.
